Arabic Arabic English English French French German German
dark

Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC

Transcenta Holding Limited announces that the TST001 US Phase I Trial has been selected as a Trial in Progress poster presentation at the 2022 ASCO GI conference from January 20 to 22, 2022 in San Francisco, CA; and the TST001 China Phase I trial data as a poster presentation at the International Gastric Cancer Congress, from March 6 to 9, 2022 in Houston, TX. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Gracell Biotechnologies Unveils Innovation Center in U.S.

Next Post

AlzeCure Holds a Digital Capital Markets Day on 18 January

Related Posts
Total
0
Share